2,657
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Inhibitory effects of fucoidan on NMDA receptors and l-type Ca2+ channels regulating the Ca2+ responses in rat neurons

, &
Pages 1-7 | Received 20 Aug 2018, Accepted 09 Nov 2018, Published online: 08 Feb 2019

References

  • Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, et al. 2006. International union of pharmacology LVIII: update on the p2y g protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev. 58:281–341.
  • Abudabbus A, Badmus JA, Shalaweh S, Bauer R, Hiss D. 2017. Effects of fucoidan and chemotherapeutic agent combinations on malignant and non-malignant breast cell lines. Curr Pharm Biotechnol. 18:748–757.
  • Berteau O, Mulloy B. 2003. Sulfated fucans, fresh perspectives: structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide. Glycobiology. 13:29R–40R.
  • Conn PJ, Pin JP. 1997. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol. 37:205–237.
  • Cui YQ, Jia YJ, Zhang T, Zhang QB, Wang XM. 2012. Fucoidan protects against lipopolysaccharide-induced rat neuronal damage and inhibits the production of proinflammatory mediators in primary microglia. CNS Neurosci Ther. 18:827–833.
  • Ferreira SS, Passos CP, Madureira P, Vilanova M, Coimbra MA. 2015. Structure–function relationships of immunostimulatory polysaccharides. Carbohydr Polym. 132:378–396.
  • Fujikawa DG. 2015. The role of excitotoxic programmed necrosis in acute brain injury. Comput Struct Biotechnol J. 13:212–221.
  • Higashijima T, Uzu S, Nakajima T, Ross EM. 1988. Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating gtp-binding regulatory proteins (G proteins). J Biol Chem. 263:6491–6494.
  • Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, Haas HL. 1997. International union of pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev. 49:253–278.
  • Holtkamp AD, Kelly S, Ulber R, Lang S. 2009. Fucoidans and fucoidanases – focus on techniques for molecular structure elucidation and modification of marine polysaccharides. Appl Microbiol Biotechnol. 82:1–11.
  • Ipsen TH, Polli FS, Kohlmeier KA. 2018. Calcium rises induced by AMPA and nicotine receptors in the ventral tegmental area show differences in mouse brain slices prenatally exposed to nicotine. Dev Neurobiol. 78:828–848. DOI: 10.1002/dneu.22607.
  • Irhimeh MR, Fitton JH, Lowenthal RM, Kongtawelert P. 2005. A quantitative method to detect fucoidan in human plasma using a novel antibody. Methods Find Exp Clin Pharmacol. 27:705–710.
  • Irving AJ, Schofield JG, Watkins JC, Sunter DC, Collingridge GL. 1990. 1s,3r-acpd stimulates and l-ap3 blocks ca2+ mobilization in rat cerebellar neurons. Eur J Pharmacol. 186:363–365.
  • Jhamandas JH, Wie MB, Harris K, MacTavish D, Kar S. 2005. Fucoidan inhibits cellular and neurotoxic effects of beta-amyloid (a beta) in rat cholinergic basal forebrain neurons. Eur J Neurosci. 21:2649–2659.
  • Julio-Pieper M, Flor PJ, Dinan TG, Cryan JF. 2011. Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues. Pharmacol Rev. 63:35–58.
  • Katz PS, Levitan IB. 1993. Quisqualate and ACPD are agonists for a glutamate-activated current in identified aplysia neurons. J Neurophysiol. 69:143–150.
  • Khakh BS, Burnstock G, Kennedy C, King BF, North RA, Seguela P, Voigt M, Humphrey PP. 2001. International union of pharmacology. XXIV. Current status of the nomenclature and properties of p2x receptors and their subunits. Pharmacol Rev. 53:107–118.
  • Kusaykin MI, Silchenko AS, Zakharenko AM, Zvyagintseva TN. 2016. Fucoidanases. Glycobiology. 26:3–12.
  • Lau A, Tymianski M. 2010. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Archiv: Eur J Physiol. 460:525–542.
  • Li H, Li J, Tang Y, Lin L, Xie Z, Zhou J, Zhang L, Zhang X, Zhao X, Chen Z, et al. 2017. Fucoidan from fucus vesiculosus suppresses hepatitis b virus replication by enhancing extracellular signal-regulated kinase activation. Virol J. 14:178.
  • Luo D, Zhang Q, Wang H, Cui Y, Sun Z, Yang J, Zheng Y, Jia J, Yu F, Wang X, et al. 2009. Fucoidan protects against dopaminergic neuron death in vivo and in vitro. Eur J Pharmacol. 617:33–40.
  • Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S. 1991. Molecular cloning and characterization of the rat NMDA receptor. Nature. 354:31–37.
  • Nakagawa T, Cheng Y, Ramm E, Sheng M, Walz T. 2005. Structure and different conformational states of native AMPA receptor complexes. Nature. 433:545–549.
  • Nakanishi S. 1992. Molecular diversity of glutamate receptors and implications for brain function. Science (New York, NY). 258:597–603.
  • Nishino T, Nishioka C, Ura H, Nagumo T. 1994. Isolation and partial characterization of a novel amino sugar-containing fucan sulfate from commercial fucus vesiculosus fucoidan. Carbohydr Res. 255:213–224.
  • Ouardouz M, Coderre E, Basak A, Chen A, Zamponi GW, Hameed S, Rehak R, Yin X, Trapp BD, Stys PK. 2009. Glutamate receptors on myelinated spinal cord axons: I. Glur6 kainate receptors. Ann Neurol. 65:151–159.
  • Perez-Reyes E, Wei XY, Castellano A, Birnbaumer L. 1990. Molecular diversity of l-type calcium channels. Evidence for alternative splicing of the transcripts of three non-allelic genes. J Biol Chem. 265:20430–20436.
  • Sevastyanova TN, Kammermeier PJ. 2014. Cooperative signaling between homodimers of metabotropic glutamate receptors 1 and 5. Mol Pharmacol. 86:492–504.
  • Sourial-Bassillious N, Rydelius PA, Aperia A, Aizman O. 2009. Glutamate-mediated calcium signaling: a potential target for lithium action. Neuroscience. 161:1126–1134.
  • Takahashi H, Kawaguchi M, Kitamura K, Narumiya S, Kawamura M, Tengan I, Nishimoto S, Hanamure Y, Majima Y, Tsubura S, et al. 2018. An exploratory study on the anti-inflammatory effects of fucoidan in relation to quality of life in advanced cancer patients. Integr Cancer Ther. 17:282–291.
  • Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R. 2010. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev. 62:405–496.
  • Wu H, Gao S, Fu M, Sakurai T, Terakawa S. 2018. Fucoidan inhibits Ca2+ responses induced by a wide spectrum of agonists for G-protein-coupled receptors. Mol Med Rep. 17:1428–1436.
  • Zhang FL, He Y, Zheng Y, Zhang WJ, Wang Q, Jia YJ, Song HL, An HT, Zhang HB, Qian YJ, et al. 2014. Therapeutic effects of fucoidan in 6-hydroxydopamine-lesioned rat model of Parkinson's disease: role of NADPH oxidase-1. CNS Neurosci Ther. 20:1036–1044.
  • Zuccolo E, Lim D, Kheder DA, Perna A, Catarsi P, Botta L, Rosti V, Riboni L, Sancini G, Tanzi F, et al. 2017. Acetylcholine induces intracellular Ca2+ oscillations and nitric oxide release in mouse brain endothelial cells. Cell Calcium. 66:33–47.